Gfcm.Bk
GFCM.BK operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment, primarily generating revenue through service provision and product sales.
Business. GFCM.BK operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment, primarily generating revenue through service provision and product sales.
Analyst recommendations
2 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
GFCM.BK operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment, primarily generating revenue through service provision and product sales.
GFCM.BK maintains a strong liquidity position, with a current ratio of 2.77, indicating the company can cover its short-term liabilities more than two and a half times over with its current assets. The company's cash and equivalents amount to 130.75 million THB, which is a significant portion of its total assets, suggesting a conservative approach to liquidity management. However, the company reported negative free cash flow of 4.30 million THB, which may indicate that capital expenditures are outpacing cash inflows from operations.
In terms of profitability, GFCM.BK's return on equity (ROE) is 3.95%, and its return on assets (ROA) is 3.34%. These figures are below the industry median for ROE and ROA, suggesting that the company is not generating returns as efficiently as its peers. The company's operating income of 34.76 million THB and net income of 22.40 million THB reflect a relatively modest profit margin, which may be a concern for investors seeking higher returns.
GFCM.BK's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This concentration may expose the company to higher risks if the segment or region experiences a downturn. The company's total revenue for the period was 352.99 million THB, with gross profit of 147.16 million THB, indicating a gross margin of approximately 41.7%.
Looking at the company's growth trajectory, there is no specific outlook provided for the current or next fiscal year. However, the company's capital expenditures of 41.59 million THB suggest a commitment to maintaining or expanding its operational capacity. The absence of a clear growth strategy or significant investment in research and development may limit the company's ability to innovate and capture new market opportunities.
The risk assessment for GFCM.BK indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's debt-to-equity ratio is 0.05, which is relatively low, suggesting a conservative capital structure. However, the negative free cash flow and the absence of a strong growth strategy may pose long-term risks to the company's financial stability.
Recent events, including analyst estimates, show a mean price target of 3.50 THB, with a median and high price target also at 3.50 THB. The lack of strong buy or buy recommendations, with only one hold recommendation, suggests a cautious outlook from analysts. This may reflect concerns about the company's growth potential and profitability.
- GFCM.BK has a strong liquidity position with a current ratio of 2.77.
- The company's ROE and ROA are below industry medians, indicating lower profitability.
- Revenue is concentrated in a single segment, increasing exposure to market risks.
- Analysts have a cautious outlook, with no strong buy recommendations.
- The company's capital expenditures suggest a focus on maintaining operational capacity.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- GFCM.BK Market data — financials · 2026-05-28
- Genesis Fertility Center PCL Market data — analyst estimates · 2026-05-28